Mineralys Therapeutics, Inc. MLYS Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Mineralys Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Mineralys Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mineralys Therapeutics, Inc.'s quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mineralys Therapeutics, Inc.'s quick ratio?
- Mineralys Therapeutics, Inc. (MLYS) reported quick ratio of 44.3× in Q1 2026.
- How has Mineralys Therapeutics, Inc.'s quick ratio changed year-over-year?
- Mineralys Therapeutics, Inc.'s quick ratio increased by 67.4% year-over-year, from 26.5× to 44.3×.
- What is the long-term trend for Mineralys Therapeutics, Inc.'s quick ratio?
- Over 3 years (2022 to 2025), Mineralys Therapeutics, Inc.'s quick ratio has grown at a 46.3% compound annual growth rate (CAGR), from 14× to 43.8×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.